Atlas Trials

Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney

Clinical trial NCT00106561 · COMPLETED

Trial details

NCT number
NCT00106561
Sponsor
Melbourne Health
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Kidney DiseaseDiabetic NephropathyGlomerulonephritisProteinuria
Start date
2002-01-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.